149 related articles for article (PubMed ID: 38880492)
1. Bibliometric analysis and description of research trends in the treatment of psoriasis with biologic agents in the past two decades (2004-2023).
Wang Y; Li J; Guo C; Yang G; Lin H; Zhang Y
J Dermatolog Treat; 2024 Dec; 35(1):2346282. PubMed ID: 38880492
[TBL] [Abstract][Full Text] [Related]
2. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
[TBL] [Abstract][Full Text] [Related]
3. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
[TBL] [Abstract][Full Text] [Related]
4. Bibliometric analysis and description of research trends on T cells in psoriasis over the past two decades (2003-2022).
Li J; Zhang J; Guo C; Lin P; Shen Q; Lin H; Zhang Y
Heliyon; 2024 Jan; 10(1):e23542. PubMed ID: 38169994
[TBL] [Abstract][Full Text] [Related]
5. Development and trends in metabolomics studies in psoriasis: A bibliometric analysis of related research from 2011 to 2024.
Zhang L; Li Y; Zhang Y; Cai Y; Li L; Ying L; Wang Q; Hu J; Jia C; Wu C; Bao Y; Jiang F; Yan W; Zeng N
Heliyon; 2024 Apr; 10(8):e29794. PubMed ID: 38681652
[TBL] [Abstract][Full Text] [Related]
6. Knowledge Mapping and Research Hotspots of Comorbidities in Psoriasis: A Bibliometric Analysis from 2004 to 2022.
Huang S; Bai Y
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837593
[No Abstract] [Full Text] [Related]
7. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
[TBL] [Abstract][Full Text] [Related]
8. Small-Molecule Inhibitors and Biologics for Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Network Meta-Analysis.
Huang IH; Wu PC; Chiu HY; Huang YH
Am J Clin Dermatol; 2024 May; 25(3):347-358. PubMed ID: 38438782
[TBL] [Abstract][Full Text] [Related]
9. Knowledge mapping of global trends for myasthenia gravis development: A bibliometrics analysis.
Jiang F; Su Y; Chang T
Front Immunol; 2023; 14():1132201. PubMed ID: 36936960
[TBL] [Abstract][Full Text] [Related]
10. Biologics for Psoriasis.
Wride AM; Chen GF; Spaulding SL; Tkachenko E; Cohen JM
Dermatol Clin; 2024 Jul; 42(3):339-355. PubMed ID: 38796266
[TBL] [Abstract][Full Text] [Related]
11. Switching Biologics in the Treatment of Psoriasis: A Multicenter Experience.
Özkur E; Kıvanç Altunay İ; Oğuz Topal İ; Aytekin S; Topaloğlu Demir F; Özkök Akbulut T; Kara Polat A; Karadağ AS
Dermatology; 2021; 237(1):22-30. PubMed ID: 31865339
[TBL] [Abstract][Full Text] [Related]
12. Global trends and hotspots of treatment for nonalcoholic fatty liver disease: A bibliometric and visualization analysis (2010-2023).
Dai JJ; Zhang YF; Zhang ZH
World J Gastroenterol; 2023 Oct; 29(37):5339-5360. PubMed ID: 37899789
[TBL] [Abstract][Full Text] [Related]
13. Knowledge mapping of immunotherapy in cervical carcinoma: a bibliometric analysis (2000-2023).
Song L; Liang X; Zhu M; Su Q; Li F
Front Immunol; 2023; 14():1328103. PubMed ID: 38264659
[TBL] [Abstract][Full Text] [Related]
14. Anti-interleukin-23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real-world practice.
Ruggiero A; Fabbrocini G; Cinelli E; Ocampo Garza SS; Camela E; Megna M
Clin Exp Dermatol; 2022 Mar; 47(3):561-567. PubMed ID: 34642965
[TBL] [Abstract][Full Text] [Related]
15. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2022 May; 5(5):CD011535. PubMed ID: 35603936
[TBL] [Abstract][Full Text] [Related]
16. Emerging trends and research foci of oncolytic virotherapy for central nervous system tumors: A bibliometric study.
Cheng K; Zhang H; Guo Q; Zhai P; Zhou Y; Yang W; Wang Y; Lu Y; Shen Z; Wu H
Front Immunol; 2022; 13():975695. PubMed ID: 36148235
[TBL] [Abstract][Full Text] [Related]
17. Short-term effectiveness of biologics in patients with moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis.
Tada Y; Watanabe R; Noma H; Kanai Y; Nomura T; Kaneko K
J Dermatol Sci; 2020 Jul; 99(1):53-61. PubMed ID: 32600737
[TBL] [Abstract][Full Text] [Related]
18. Worldwide productivity and research trend of publications concerning tumor immune microenvironment (TIME): a bibliometric study.
Liu YG; Jiang ST; Zhang L; Zheng H; Zhang T; Zhang JW; Zhao HT; Sang XT; Xu YY; Lu X
Eur J Med Res; 2023 Jul; 28(1):229. PubMed ID: 37430294
[TBL] [Abstract][Full Text] [Related]
19. Knowledge mapping of targeted immunotherapy for myasthenia gravis from 1998 to 2022: A bibliometric analysis.
Su Y; Ruan Z; Wang R; Hao S; Tang Y; Huang X; Gao T; Li Z; Chang T
Front Immunol; 2022; 13():998217. PubMed ID: 36248874
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials.
Reich K; Burden AD; Eaton JN; Hawkins NS
Br J Dermatol; 2012 Jan; 166(1):179-88. PubMed ID: 21910698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
